Skip to main content
Clinical Trials/NCT06757985
NCT06757985
Not yet recruiting
Not Applicable

Doppler Echocardiography Versus Clinical Targets Guided Therapy on the Outcome of Postpartum Septic Shock, a Randomized Controlled Trial

Assiut University1 site in 1 country60 target enrollmentDecember 30, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Doppler Echocardiography
Sponsor
Assiut University
Enrollment
60
Locations
1
Primary Endpoint
SOFA score
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

Postpartum sepsis is widely known as a preventable main cause of maternal morbidity and mortality. According to the World Health Organization, approximately 11% of the estimated maternal deaths worldwide were attributed to sepsis. Recent global assessments indicate that obstetric infections rank as the third most prevalent cause of maternal death, with a prevalence mainly observed in low- and middle-income nations.

Detailed Description

The management of septic shock is a major medical concern. Early goal-directed therapy emerged as a novel approach for reducing sepsis mortality and was incorporated into Surviving Sepsis Campaign guidelines in 2012. Early detection of sepsis, rapid initiation of antibiotics and effective resuscitation with fluids, vasopressors, and inotropes were important concerns. However, many randomized trials were done to examine the effect of EGDT on morbidity and mortality and showed that EGDT was not associated with a significant reduction in mortality in patients with septic shock compared to usual care. That it wasn't addressed in recent guidelines in 2016 and 2021.

Registry
clinicaltrials.gov
Start Date
December 30, 2024
End Date
November 30, 2026
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ghada Mohammed AboelFadl

Principal investigator

Assiut University

Eligibility Criteria

Inclusion Criteria

  • postpartum women, within 6 weeks following delivery
  • meeting the third international consensus definitions for septic Shock (2016) (Sepsis-3): acute persisting hypotension requiring vasopressors to maintain mean arterial pressure (MAP) ≥ 65 mm Hg and having a serum lactate \> 2 mmol/L (18 mg/dL) despite adequate volume resuscitation

Exclusion Criteria

  • Patient refusal
  • History of any chronic cardiac disease
  • Requirement for immediate surgery
  • Hypotension attributable to another cause
  • Do-not-resuscitate status
  • Contraindication to central venous catheter placement
  • Difficult transthoracic echocardiographic evaluation
  • Primary cardiogenic cause of shock, instead of sepsis.

Outcomes

Primary Outcomes

SOFA score

Time Frame: 48 hours.

The change in Sequential Organ Failure Assessment (SOFA score)

Study Sites (1)

Loading locations...

Similar Trials